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Abstract
Background: Evidence indicates that Bax functions as a ‘‘lipidic’’ pore to regulate mitochondrial outer membrane
permeabilization (MOMP), the apoptosis commitment step, through unknown membrane elements. Here we show
mitochondrial ceramide elevation facilitates MOMP-mediated cytochrome c release in HeLa cells by generating a previously-
unrecognized mitochondrial ceramide-rich macrodomain (MCRM), which we visualize and isolate, into which Bax integrates.
Methodology/Principal Findings: MCRMs, virtually non-existent in resting cells, form upon irradiation coupled to ceramide
synthase-mediated ceramide elevation, optimizing Bax insertion/oligomerization and MOMP. MCRMs are detected by
confocal microscopy in intact HeLa cells and isolated biophysically as a light membrane fraction from HeLa cell lysates.
Inhibiting ceramide generation using a well-defined natural ceramide synthase inhibitor, Fumonisin B1, prevented radiation-
induced Bax insertion, oligomerization and MOMP. MCRM deconstruction using purified mouse hepatic mitochondria
revealed ceramide alone is non-apoptogenic. Rather Bax integrates into MCRMs, oligomerizing therein, conferring 1–2 log
enhanced cytochrome c release. Consistent with this mechanism, MCRM Bax isolates as high molecular weight ‘‘pore-
forming’’ oligomers, while non-MCRM membrane contains exclusively MOMP-incompatible monomeric Bax.
Conclusions/Significance: Our recent studies in the C. elegans germline indicate that mitochondrial ceramide generation is
obligate for radiation-induced apoptosis, although a mechanism for ceramide action was not delineated. Here we
demonstrate that ceramide, generated in the mitochondrial outer membrane of mammalian cells upon irradiation, forms a
platform into which Bax inserts, oligomerizes and functionalizes as a pore. We posit conceptualization of ceramide as a
membrane-based stress calibrator, driving membrane macrodomain organization, which in mitochondria regulates intensity
of Bax-induced MOMP, and is pharmacologically tractable in vitro and in vivo.
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Introduction
We recently reported that the ceramide is an essential element in
the mitochondrial phase of apoptosis in the C. elegans germline [1].
Ionizing radiation activated the de novo ceramide synthetic pathway
via the C. elegans ceramide synthases (CSs) HYL-1 and LAGR-1,
increasing ceramide concentration in germ cell mitochondrial
membranes. Mitochondrial ceramide regulated EGL-1 (BH3
ortholog)-mediated displacement of CED-4 (APAF-1 ortholog) from
the CED-9 (Bcl-2 ortholog)/CED-4 complex, thus activating CED-3
caspase,conferring the apoptoticeffectorphase[1].WhilegeneticCS
depletion proved ceramide obligate for mitochondrial CED-4 release,
a mechanism for ceramide function remains unknown.
In mammalian cells, a complementary pathway involving
mitochondrial outer membrane permeabilization (MOMP) initi-
ates the commitment phase of the apoptotic response. MOMP is
regulated either by opening of the inner mitochondrial membrane
permeability transition pore or by insertion of pro-apoptotic Bcl-2
family members into the MOM. The principal mammalian pro-
apoptotic Bcl-2 protein is a-helical Bax, which undergoes a
conscripted sequence of events en route to MOMP [2]. Bax contains
three Bcl-2 homology domains (BH1-3) and a C-terminal
transmembrane (TM) domain, arranged in 9 a-helices [3,4]. This
spatial configuration is reminiscent of the structure of a-helical
pore-forming toxins, including diphtheria toxin, colicins and d-
endotoxin [4]. Inactive Bax resides as a 21 KD monomer in
cytosol where the amphiphatic helices a1–4 and a7–8 provide a
hydration shell for the a5–a6-helical hydrophobic hairpin core in
an arrangement that generates an elongated hydrophobic cleft
occupied by the hydrophobic a9-helix, thereby constraining the
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undergoes conformational changes that free up the TM domain,
which eventually inserts through the MOM to tether Bax to
mitochondria. X-ray and NMR structure evidence, and model
membrane studies, suggest the a5–a6-helical anti-parallel duplex
of mitochondrial-bound Bax thereafter inserts through the MOM
to trigger MOMP [2,3,5].
Emerging evidence suggests that Bax insertion into the MOM
by itself may be insufficient for pore activation [6,7], but that
homodimerization through BH domain interaction [3,8] and
higher order oligomerization with other membrane resident
proteins are required. Furthermore, studies with pore-forming
toxins, and with His-Bax [7], indicate the pore once assembled
requires formation of a toroidal structure, where pore walls
interact directly with membrane lipids, such that non-bilayer
structures are generated, enabling pore opening [7,9]. Mitochon-
drial membrane components that might undergo rearrangement
to generate a functional Bax ‘‘lipidic’’ pore remain largely
unknown. Hence, at least two lipid events requiring distinct Bax
domains are involved in insertional activation of Bax at the MOM.
A lipid candidate potentially involved in Bax-mediated MOMP
is the sphingolipid second messenger ceramide. A substantive
literature identifies mitochondrial ceramide elevation preceding
MOMP for a variety of distinct stresses [10,11,12,13,14].
Furthermore, in isolated mitochondria ceramide and recombinant
Bax act coordinately to release cytochrome C [15,16,17].
Consistent with this latter observation ceramide is capable of
inducing an activating conformational change in Bax in isolated
mitochondrial membranes [17]. Lastly, synergism was detected
upon addition of exogenous ceramide and recombinant Bax to
isolated yeast mitochondria which are devoid of Bcl-2 family
proteins, suggesting a direct lipid-protein interaction [15].
Furthermore, recent studies of a-helical and b-strand toxin
activation indicate an initial step often involves targeting plasma
membrane cholesterol- and glycosphingolipid-enriched microdo-
mains (GEMs, also known as rafts), and macrodomain platforms
derived thereof [18]. GEMs exist constitutively in the outer plasma
membrane, phase-separated from the bulk plasma membrane
because the sphingosine backbone of sphingolipids forms a
network of hydrogen bonds that stabilize a liquid ordered phase
within the liquid disordered bilayer [19]. GEMs segregate specific
proteins and lipids that operate as ‘‘receptors’’ for antigens, growth
factors and cytokines, promoting protein oligomerization and
signal transmission [20]. Consistent with this model, a-helical and
b-strand pore-forming toxins recognize ‘‘receptors’’ within GEMs.
Aerolysin and Cry proteins target GPI-linked GEM proteins,
lysenin targets sphingomyelin, and some b-strand pore-forming
toxins are cholesterol-binding cytolysins [21,22,23]. Pharmacolog-
ic GEM disruption dramatically affects toxin pore-forming
capability [23,24,25,26]. A large literature now reports that
specific stresses (i.e. oxidative, heat, ionizing radiation, UV-C,
microbial pathogens and TNF-superfamily members) may induce
structural re-organization of plasma membrane GEMs to form
large (1–5 microns in diameter) sphingolipid- and cholesterol-rich
platforms into which select proteins traffic, oligomerize and signal
[for review see [27]]. This process is initiated by acid
sphingomyelinase-mediated sphingomyelin hydrolysis to ceramide,
which drives GEM coalescence based largely on hydrophobic
forces [19,28,29]. In contrast to GEMs, which are too small to
visualize by conventional microscopy, these ceramide-rich macro-
domains (CRMs) can be detected by confocal microscopy [30,31].
In at least one instance such CRMs regulate channel properties.
Pseudomonas aeruginosa binds asialoGM1 within GEMs, stimulating
formation of ceramide-rich platforms into which the cystic fibrosis
transmembrane conductance regulator (CFTR) chloride channel
inserts, oligomerizes and becomes functional. This response was
abrogated in acid sphingomyelinase-deficient cells [28].
Here we visualize and isolate a previously-unrecognized
mitochondrial ceramide-rich macrodomain (MCRM) into which
Bax integrates. MCRM formation is coupled to radiation-induced
activation of CS and ceramide elevation within HeLa cell MOM,
optimizing Bax insertion/oligomerization therein, triggering
MOMP. Whereas pharmacologic inhibition of CS abrogates
MCRM formation, Bax insertion/oligomerization and MOMP,
MCRMs appear to bestow Bax pore-forming capability. We posit
conceptualization of ceramide as a membrane-based stress
calibrator, driving membrane macrodomain organization, which
in mitochondria regulates intensity of Bax-induced MOMP.
Materials and Methods
Cell culture, irradiation and FB1-treatment
HeLa cells (ATCC) were cultured in low glucose Dulbecco’s
Modified Eagle’s Medium (DMEM from Gibco BRL) containing
10% fetal bovine serum (FBS), penicillin (50 units/ml), strepto-
mycin (50 mg/ml) and 2 mM glutamine. 1 h prior to irradiation,
HeLa cells were changed to medium containing 0.2% FBS. BAEC
were cultured until confluent in low glucose DMEM supplemented
with 10% normal calf serum, 1 ng/ml basic FGF (Scios Inc.),
penicillin (50 units/ml), streptomycin (50 mg/ml) and 2 mM
glutamine. After confluence, BAEC were maintained in DMEM
with 5% heat inactivated normal calf serum. At 24 h before
irradiation, medium was changed to DMEM with 0.2% human
albumin (HA) containing 50 mg/ml pentosan polysulfate (PPS;
Sigma). FB1 (Sigma or Biomol) was solubilized in phosphate-
buffered saline (PBS; 10 mM KH2PO4, 150 mM NaCl, 3 mM
NaH2PO4?7H2O) at a concentration of 5 mM and added to cells
at final concentration of 10–50 mMF B 1. Note commercially-
available FB1 is a biologic isolate from Fusarium verticillioides and
Fusarium proliferatum that displays batch-to-batch variation. Hence,
each batch must be tested empirically for effectiveness. Irradiation
was carried out at 22uC using a Cs-137 irradiator (Shepherd
Mark-I, model 68, SN 643) at a dose rate of 240 cGy/min.
Antibodies and Immunoblotting
Anti-Bax (N20, Santa Cruz; 0.4 mg/ml or YTH-6A7, Trevigen;
0.2 mg/ml), anti-Bak (NT, Upstate Biotechnology; 2 mg/ml), anti-
Bcl-xL (Transduction Laboratories; 0.5 mg/ml), anti-BID (AF860
R&D; 1 mg/ml), anti-BIM (Calbiochem; 1:1000), anti-PUMA (N-
terminal, Sigma; 1 mg/ml), anti-GST (Z-5, Santa Cruz; 0.2 mg/ml),
anti-Fis1 (Imgenex; 1:1000), anti-COX II (12C4, Molecular Probes;
0.2 mg/ml), anti-COX IV (20E8, Molecular Probes; 0.2 mg/ml),
anti-PDH-E1a (9H9, Molecular Probes; 0.2 mg/ml), anti-Hsp60
(LK-1,Calbiochem;0.05 mg/ml),anti-KDEL(10C3,Abcam;1:50),
anti-VDAC [31HL(Ab-3), Calbiochem; 2 mg/ml], anti-Climp63
(G1/296, Alexis; 1 mg/ml), anti-Calnexin (H-70, Santa Cruz;
0.2 mg/ml) or anti-metaxin (Transduction laboratories; 0.5 mg/ml)
was used as indicated. Proteins were separated on a 12–15% SDS-
PAGE gel and transferred to 0.2 mm PVDF membrane (Biorad).
Then the blot was incubated with 5% Blotto (Biorad) in TBST
(20 mM Tris–HCl, pH 7.5, 500 mM NaCl, 0.1% Tween 20) for
1 h at room temperature. After brief washing with TBST, the blot
was incubated with primary antibodies in TBST containing 2.5%
BSA for 16 h at 4uC. This was followed by extensive washing with
TBST and incubation with the appropriate secondary antibodies
conjugated to HRP (Amersham) in TBST containing 5% Blotto for
1 h at room temperature. After extensive washing with TBST,
immunolabeled proteins were revealed using ECL kit (Amersham).
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Apoptotic HeLa cells were stained with bis-benzimide Trihy-
drochloride (Hoechst #33258; Sigma) and quantified by fluores-
cence microscopy, as described [32].
Caspase assay
Caspase 3 activity was measured fluorospectrometrically using
Z-DEVD-AFC as substrate as described [33].
Cytochrome c release in intact cells
Cytosolic cytochrome c content was measured according to
Newmeyer [34] by either immunoblotting using mouse monoclo-
nal anti-cytochrome c antibody (7H8.2C12, PharMingen; dilution
1:500) or by ELISA (Human Cytochrome c Quantikine ELISA
Kit, R&D).
Isolation of subcellular fractions from HeLa cells and
BAEC
Mitochondria and endoplasmic reticulum from HeLa cells and
BAEC were isolated by differential centrifugation via a discontin-
uous sucrose gradient as described [35], with modification. All
procedures were conducted at 4uC. For these studies, cell
monolayers were washed twice and scraped into ice-cold PBS.
Cells were collected by centrifugation at 5006g for 10 min, then
washed and resuspended in SHE buffer [250 mM sucrose, 10 mM
HEPES-KOH pH 7.4, 1 mM EGTA, protease inhibitor cocktail
(Roche)], and homogenized twice by 20 strokes in a loose-fitting
Dounce homogenizer. Cell debris and nuclei were pelleted by
centrifugation at 8006g for 5 min. The postnuclear supernatant
was collected and centrifuged at 10,0006g for 10 min and the
pellet containing heavy membrane fractions (P10) was resuspended
in 20 ml SHE buffer and centrifuged through an underlayed
cushion of 5 ml HE medium containing 750 mM sucrose at
10,0006g for 30 min. The resulting mitochondrial-enriched pellet
was resuspended in SHE buffer and further purified by a second
discontinuous sucrose gradient centrifugation as above. MAM-free
mitochondria were isolated by Percoll gradient according to the
method of Vance [14] with slight modification. For these studies,
heavy membrane fractions (P10) were layered on top of 20 ml of
medium consisting of 2.2 ml of 2.5 M sucrose, 6.55 ml of Percoll
and 12.25 ml of 10 mM HEPES, pH 7.4, 1 mM EGTA, and
centrifuged at 100,0006g for 1 h in a Beckman Ti-55.2 rotor. Two
bands were recovered from the gradient; a lower band
corresponding to mitochondria (Rf: 0.48) and an upper band
containing MAM (Rf: 0.23) [36]. Mitochondria were collected
using a Pasteur pipette, diluted 10-fold with SHE buffer and
washed twice by centrifugation at 10,0006g for 10 min to remove
the Percoll. The MAM fraction was diluted with SHE buffer and
pelleted by centrifugation at 100,0006g for 1 h in a Beckman Ti-
55.2 rotor. To isolate the ER-enriched membrane fraction, the
supernatant of the P10 fraction was centrifuged at 100,0006g for
1 h. Fractionation was monitored by immunoblotting using mouse
monoclonal anti-COX II (mitochondrial marker) and rabbit
polyclonal anti-Climp63 or anti-Calnexin (ER Markers).
Bax insertion status by alkali extraction of the
mitochondria
For measurement of Bax insertion, mitochondria, subjected to
alkali extraction by incubation in freshly prepared 0.1 M Na2CO3
(pH 11.5) for 60 min at 4uC, were pelleted by centrifugation at
100,0006g for 30 min at 4uC [37,38]. Supernatant (alkaline-
sensitive fraction) and mitochondrial pellet (alkaline-resistant
fraction) were separated, mitochondrial membranes were lysed
in RIPA buffer, and fractions were analyzed by immunoblotting
using anti-Bax antibody.
Bax oligomerization status by gel filtration
Gel filtrations were performed at 4uC on a 1.5655 cm
Sephacryl 200 column equilibrated in 25 mM HEPES-KOH
pH 7.4, 137 mM NaCl, 2 mM EDTA, 10% Glycerol, 1% or 2%
(w/v) CHAPS and calibrated with thyroglobulin (669 KD), ferritin
(440 KD), aldolase (158 KD), bovine serum albumin (67 KD),
ovalbumin (43 KD), chymotrypsinogen A (25 KD), and ribonu-
clease A (13.7 KD) (Amersham Biosciences). A 1.5 ml sample was
loaded onto the column and fractions of 1 ml were collected at a
flow rate of 0.5 ml/min. Aliquots of 400 ml from the fractions were
analyzed by Western blotting after 20% TCA precipitation.
Samples were separated on 12% or 15% SDS-PAGE under
reducing conditions and transferred to 0.2 mm PVDF membranes
(Biorad). Proteins were detected with the specific antibodies as
indicated in the figures, and the blots were developed with the
ECL system from Amersham Pharmacia Biotech.
Ceramide synthase activity assay
For these studies, 75610
6 cells were pelleted, washed once with
cold PBS, and resuspended in 300 ml of homogenization buffer
[25 mM HEPES pH 7.4, 5 mM EGTA, 50 mm NaF, protease
inhibitor cocktail (Roche)]. Cells were disrupted on ice by
sonication, and lysates centrifuged at 8006g for 5 min. The
postnuclear supernate was centrifuged at 100,0006g for 1 h and
the microsomal pellet (P100) was resuspended into 1 ml of
homogenization buffer. To measure ceramide synthase activity
in sub-cellular fractions, mitochondrial-enriched and endoplasmic
reticulum-enriched fractions were prepared as described above.
Membranes were prepared fresh daily. The assay for ceramide
synthase (EC 2.3.1.24) activity was based on the procedure of
Harel and Futerman [39]. 75 mg protein were incubated in a 1 ml
reaction mixture containing 2 mM MgCl2, 20 mM HEPES
pH 7.4, 20 mM defatted BSA (Sigma), and varying concentrations
(0.2–20 mM) of dihydrosphingosine (sphinganine; Biomol), 70 mM
unlabeled palmitoyl-coenzyme A (Sigma), and 3.6 mM (0.2 mCi)
[1-
14C]palmitoyl-coenzyme A (55 mCi/mmol; American Radio-
labeled Chemicals). Dihydrosphingosine was dried under N2 from
a stock solution in 100% ethanol and dissolved by sonication in
reaction mixture prior to addition of protein. The reaction was
started by addition of palmitoyl-coenzyme A at 37uC, and after
1 h stopped by extraction of lipids using 2 ml of chloroform:-
methanol (1:2, v/v). 500 ml of lower phase was dried under N2 and
dihydroceramide resolved by thin layer chromatography using a
solvent system of chloroform:methanol:3.5 N ammonium hydrox-
ide (85:15:1). Radiolabeled dihydroceramide was identified by
iodine vapor staining based on comigration with ceramide
standards (Type III, Sigma), and quantified by liquid scintillation
counting. The velocity of the reaction was linear for at least 2 h,
and the amount of palmitoyl-coenzyme A consumed did not
exceed 5% of total. Ceramide synthase activity was unaffected by
CHAPS (0.5–4%) or Triton X-100 (0.05–1%), except at the
highest concentrations where both detergents attenuated activity
20–30%.
Lipid analysis
Ceramide mass was quantified by the diacylglycerol kinase assay
as described [32]. Cholesterol was quantified using Amplex Red
Cholesterol Assay Kit according to manufacturer’s instruction
(Invitrogen). Neutral sphingolipids and gangliosides were analyzed
by HPTLC or immune-HPTLC as described [40] with modifi-
cation. Sphingomyelin was analyzed according to Mallikarjunes-
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with CHCl3:MeOH:HCl (100:100:1 v/v/v), and the extract was
washed once with an equal volume of pre-equilibrated upper
phase, followed by resolution on Silica gel 60 A ˚ HPTLC plates
(Whatman) using CHCl3:MeOH:H20 (65:25:4) as solvent. Sphin-
gomyelin was visualized with 7% phosphomolybdic acid in ethanol
(Sigma) followed by charring, and quantified by comparison to a
concomitantly-run standard curve of known quantities of sphin-
gomyelin.
Cellular ceramide localization by confocal microscopy
HeLa cells, grown on coverslips in 6-well plates, were washed 3
timeswith coldPBS,and fixed with 4%Formalin inPBS for 15 min.
Cells were then permeabilized by incubation with-20uC acetone/
methanol (1:1) for 10 min after 3 times of washing with PBS. After
blocking with 3% goat serum and 3% FBS diluted inPBS for 16 h at
4uC, cells were incubated with anti-CoxI-Alexa 488 conjugated
(Invitrogen; 1:75) diluted in cold wash buffer (1% FBS, 0.025%
Tween20 in PBS) at 22uC for 45 min. Cells were then washed 3
times for 5 min with cold wash buffer followed by incubation with
monoclonal anti–ceramide (Alexis; 1:30) at 22uC for 45 min. After
washing 3 times with cold wash buffer, cells were incubated with
Cy3-conjugated goat anti-mouse IgM (Jackson ImmunoResearch;
1:100) at 22uC. After 45 min, cells were washed 3 times with cold
wash buffer, and mounted on slides using the ProLong Antifade Kit
(Invitrogen). When indicated, Mitotracker Red CMXRos (50 nM)
(Invitrogen) was added to the culture medium at 37uC for 30 min to
stain mitochondria before fixation. Images were acquired with a
Leica TCSSP2 AOBSconfocalmicroscopeequipped witha 6361.4
NA OIL DIC D Objective combined with 46 scan zoom. Co-
localization analysis was performed with MetaMorph 7.5 software.
For ER staining, anti-KDEL (Abcam; 1:50) and anti–ceramide
(Alexis; 1:20) were employed in combination with Texas red-
conjugated goat anti-mouse IgG (Jackson ImmunoResearch; 1:100)
and Cy2-conjugated goat anti-mouse IgM (Jackson ImmunoRe-
search; 1:100), respectively.
Preparation of recombinant full length Bax and BaxDC
Purified recombinant full length Bax was kindly provided by Dr.
Richard Youle [see [42]]. Mouse BaxDC with or without a GST
tag was prepared as described [16]. Briefly, 50 ml of an overnight
culture of E. coli BL21 expressing pGEX-4T-2 BaxDC was
inoculated into 1000 ml of LB-medium containing 50 mg/ml of
ampicillin and grown at 37uCt oa nA 600 0.6–0.8. After addition of
0.1 mM IPTG, cells were grown for 2 h at 25uC and collected by
centrifugation. Cell pellets were resuspended in 30 ml lysis buffer
(50 mM Tris pH 8.0, 150 mM NaCl, 1% Tween 20, 0.1% 2-
mercaptoethanol, 5 mM EDTA, 1 mM PMSF, protease inhibitor
cocktail) and disrupted by sonication. The cell lysate was
centrifuged at 28,0006g for 20 min at 4uC. GST-BaxDC was
purified using the Bulk GST Purification Kit (Amersham). GST
tag was removed from the recombinant GST–BaxDC proteins
bound to glutathione-Sepharose 4B resin by thrombin (10 units,
Amersham) according to manufacturer’s instructions. Released
BaxDC protein was purified on a Mono-Q Sepharose column
using a linear gradient of 0.5 M NaCl, pH 8.0 and dialyzed in
dilution buffer (20 mM HEPES pH 7.5, 100 mM KCl, 20 mM
MgCl2, 1 mM EDTA) for 16 h at 4uC. Ultrafree Centrifuge Filter
Devices (Millipore) were used to concentrate purified protein.
Recombinant BaxDC was stored in dilution buffer.
Preparation of C16-ceramide and C16-dihydroceramide
C16-ceramide (Biomol) or C16-dihydroceramide (Toronto Re-
search Chemical Inc.) was dissolved in ethanol:dodecane (98:2, v/
v) at 37uC with occasional vortexing, and further diluted to a 1%
final solvent concentration with experimental reaction buffers.
Bax insertion into and cytochrome c release from HeLa
cell mitochondria ex vivo
Bax or tBid (R&D Systems, Inc.) in Bax dilution buffer [20 mM
HEPES pH 7.4, 10 mM KCl, 20 mM MgCl2,1m ME D T A ]w a s
incubated with 50 mgo ft h eP 10-mitochondria-enriched fraction in
the presence or absence of C16-ceramide in 50 ml MSB buffer
[400 mM mannitol, 50 mM Tris-HCl pH 7.2, 4 mM MgCl2,
10 mM KH2PO4,5 0mM rotenone, 5 mM succinate, 5 mg/ml fatty
acid free bovine serum albumin (BSA; Sigma)] for 30 min or 1 h at
30uC. Reaction samples were centrifuged at 14,0006g for 5 min, and
supernatantsand mitochondrial pellets were analyzed for cytochrome
c release. For measurement of Bax insertion, mitochondrial pellets
were subjected to alkali extraction as described above and alkaline-
sensitive and alkaline-resistant fractions were analyzed by immuno-
blotting using anti-Bax or anti-GST antibodies.
Isolation of mitochondria from mouse liver
Mouse liver mitochondria were isolated as described [16] with
modification. Livers were surgically removed from 8 week old C57BL/
6 black mice (Jackson Laboratory, Bar Harbor, ME) sacrificed by CO2
asphyxiation under protocol 09-08-016 in compliance with the
guidelines of the Institutional Animal Care and Use Committee
(IACUC) of MSKCC. Briefly, isolated liver tissue was washed twice
and minced in ice-cold Buffer A (0.25 M sucrose, 10 mM HEPES
pH 7.4, 0.5 mM EGTA). Minced tissue was then re-washed in Buffer
A and homogenized (0.3 g of liver/ml of buffer) on ice for 3 min using
a glass homogenizer with a loose-fitting pestle. Homogenates were
centrifuged at 6006g for 15 min, and the resulting pellets containing
nuclei and undisrupted cells were discarded. Supernatants were
centrifuged at 97506g for 15 min, and the resulting pellet was
resuspended in Buffer A and centrifuged at 97506g for 10 min. The
pellet was washed 3 more times in Buffer A and once in Buffer B
(0.25 M sucrose, 10 mM HEPES pH 7.4). The final mitochondrial
pellet was resuspended in Buffer B at 50 mg protein/ml. All steps were
carried out at 0–4uC. Mice were housed at the animal core facility of
Memorial Sloan-Kettering Cancer Center. This facility is approved by
the American Association for Accreditation of Laboratory Animal
Care and is maintained in accordance with the regulations and
standards of the United States Department of Agriculture and the
Department of Health and Human Services, National Institutes of
Health. The Institutional Animal Care and Use Committee at
Memorial Sloan-Kettering Cancer Center approved these mice
experiments under Protocol # 09-08-016.
Uptake of C16-ceramide or C16-dihydroceramide by
isolated mouse liver mitochondria
Isolated mitochondria (1 mg/ml) were incubated with C16-
ceramide or C16-dihydroceramide (0–5 mM; 1% final solvent
concentration) in a KCl-based medium [20 mM HEPES, pH 7.4,
150 mM KCl, 25 mM NaHCO3, 1 mM MgCl2, 3 mM NaH2PO4,
250 mM sucrose, 1 mM glutamate/malate, 5 mg/ml fatty acid free
BSA] for 5 min at 37uC. Thereafter, samples were centrifuged at
10,0006g for 10 min at 4uC, the mitochondrial pellet was
resuspended in 16PBS buffer, and ceramide levels in mitochondria
(600 mg) were quantified by the diacylglycerol kinase assay.
Formation of MCRMs within and cytochrome c release
from mouse liver mitochondria ex vivo
Recombinant full length Bax or BaxDC in Bax dilution buffer
was incubated with or without C16-ceramide with isolated
Ceramide-Rich Macrodomains Functionalize Bax
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37uC. Reaction samples were centrifuged at 14,0006g for 5 min at
4uC and the supernatant containing proteins released from
isolated mitochondria and pellet containing retained mitochon-
drial proteins were analyzed for cytochrome c. For MCRM
isolation, the mitochondrial pellet was subjected to 5–30%
continuous sucrose density gradient after incubation with 0.05%
Triton X-100 as below.
Isolation of MCRM by sucrose density gradient
Isolation of HeLa and mouse liver MCRM was based on
concepts derived from isolation of detergent-insoluble raft-like
plasma membrane macrodomains [43]. Identification of HeLa
and mouse liver MCRM initially involved extensive detergent dose
titration. Mitochondria (3.3 mg/ml), isolated in SHE buffer, were
incubated on ice for 30 min with Triton X-100 (0.01–1%) or
CHAPS (0.1–2%), and solubilized mitochondrial proteins were
separated from insoluble proteins by centrifugation at 14,0006g
for 5 min at 4uC. Extent of solubilization of the inner
mitochondrial membrane protein COXIV was confirmed by
Western blot. The lowest concentrations that induced complete
COXIV solubilization, 0.05% Triton X-100 for mouse liver
mitochondria and 0.15% Triton X-100 or 1% CHAPS for HeLa
mitochondria, were selected for MCRM isolation. For these
studies, mitochondria (3.3 mg/ml) were treated on ice with
detergent for 30 min in 16MBS buffer (25 mM MES pH 6.5,
150 mM NaCl), followed by homogenization with 20 strokes of a
loose-fitting dounce homogenizer or by sonication (3610 sec). The
homogenate was adjusted with 80% sucrose in MBS buffer to 40%
final sucrose concentration and transferred to a 12 ml ultracen-
trifuge tube. A continuous gradient consisting of 4 ml of 5% and
6 ml of 30% sucrose, or a discontinuous gradient consisting of
5 ml of 5% and 5 ml of 30% sucrose was layered on top of the
homogenate, and samples were ultracentrifuged at 182,0006g for
16 h in Beckman SW41 rotor at 4uC. As with isolation of plasma
membrane platforms, this procedure yielded an opaque detergent
insoluble band at fraction 5–7 of the gradient. One ml fractions
were collected from atop the gradient and profiled for proteins by
Western blotting after 20% TCA precipitation, and for lipids as in
Experimental Procedures. For mini-discontinuous sucrose gradi-
ent, 80 ml of homogenates adjusted to 40% sucrose were
transferred to an ultracentrifuge tube and overlaid successively
with 80 ml of 30% sucrose and 80 ml of 5% sucrose. Samples were
centrifuged at 182,0006g for 18 h in Beckman TLA 100 rotor at
4uC, and three 80 ml fractions were collected from the top. Pellets
were resuspended in 80 ml MBS by brief sonication.
Staining and visualization of MCRMs
MitoTracker was used to outline mitochondrial anatomical
boundaries for ease of co-localization, and hence cannot bestow an
MCRM artifact. In studies examining MCRM formation upon
radiation in HeLa cells, mitochondria were stained by incubating
live cells with 100 nM MitoTracker Deep Red 633 for 30 min at
37uC as per manufacturer instructions before mitochondrial
isolation. However, for ex vivo studies with isolated mitochondria
examining the effects of ceramide and Bax on MCRM formation,
the isolated mitochondria were stained either before or after
fixation. When staining live mitochondria prior to fixation,
mitochondria were pre-incubated with 200 nM MitoTracker
Deep Red 633 in 2.5% FBS and 2.5% goat serum in PBS for
1 h on ice. MitoTracker is an organic dye with a charge that
directs its binding to membranes with a potential, i.e. live
mitochondria. However, its hydrophobic nature also permits
binding membranes lacking a potential after fixation, if incubation
is prolonged. Therefore, the fixed staining approach was used for
the majority of ex vivo experiments for ease of experimental
procedure. For staining of fixed mitochondria, mitochondria were
fixed for 45 min with 2% formaldehyde, pelleted by centrifugation
at 60006g for 5 min, followed by brief washing with PBS, and
incubation with 200 nM MitoTracker Deep Red 633 in 2.5% FBS
and 2.5% goat serum in PBS for 16 h at 4uC. Mitochondria,
stained with MitoTracker, were washed once in Wash Buffer (1%
FBS, 0.025% Tween 20 in 16PBS), and incubated with anti-
ceramide (Alexis, MID15B4; 1:30) and/or anti-Bax (6A7; 1:50,
Calbiochem or D21; 1:10, Santa Cruz) antibodies in Wash Buffer
for 45 min. Mitochondria were then washed, followed by
incubation with Cy3-conjugated goat anti-mouse IgM (Jackson
ImmunoResearch; 1:100) and/or Cy2-conjugated goat anti-mouse
IgG (Jackson ImmunoResearch; 1:100) or Alexa Fluor 488-
conjugated goat anti-rabbit IgG (Molecular Probes; 1:100)
secondary antibodies, respectively. After 45 min, mitochondria
were washed 3 times, and then once in 0.025% Tween 20 in PBS.
All staining steps were at 4uC. After staining, mitochondrial pellets
were resuspended in 20 ml 0.025% Tween 20 in PBS. 5 mlo f
mitochondrial suspension was spread on slide using a cover slip
and mounted using the ProLong Gold Antifade Reagent
(Invitrogen). Images were acquired with a Leica TCS AOBS
SP2 confocal microscope equipped with a 10061.4 NA OIL DIC
D Objective combined with 26 scan zoom. Co-localization
analysis was performed with MetaMorph 7.5 software.
Statistical Analysis
Statistical analysis was performed by Student’s t-test or linear
regression analysis with 95% confidence estimation for ED50.
Results
Mitochondrial ceramide elevation precedes Bax
activation in irradiated HeLa cells
Morphologic evidence of apoptosis was detected in 5–15 Gy
irradiated HeLa cells by 36 h and became significant at 48 h
(Figure 1A; p,0.001 vs. control). Increased cytosolic effector
caspase 3 activity, measured fluorometrically by cleavage of the
substrate Z-DEVD-AFC, was similarly detected by 30 h post-
irradiation, peaking at 36 h, remaining elevated for at least 72 h
after 10 Gy (see Figure 2E for 36 h data). Cytochrome c release
from mitochondria into cytosol was detected at 30–32 h after
10 Gy by Western analysis (Figure 1B) and was maximal at 36 h.
Consistent with the cytochrome c release profile, Bax insertion into
the MOM also began at 30 h, peaking at 34 h after 10 Gy (Figure
S1A). In agreement with previous studies [44], Bax insertion
occurred without apparent translocation from cytosol (not shown),
but rather from a Bax pool loosely attached to unirradiated HeLa
mitochondria but not inserted into MOM [37,45]. This pool,
which is readily removed by 100 mM Na2CO3 washing and does
not spontaneously induce MOMP [45,46], represents the large
majority of endogenous Bax co-isolated with HeLa mitochondria
(estimated at ,80% in our preparations based on semi-
quantitative densitometry normalized for protein recovery;
n=8). At 34 h post-irradiation, the fraction of Bax inserted into
the MOM had increased 4–5-fold (Figure S1A, p,0.001 vs.
control unirradiated, n=6). Bax multimerization into low
molecular weight (not shown) and higher molecular weight
oligomers (Mr 360 KD) occurred concomitant with Bax insertion
(Figure S1B). Whereas mitochondrial Bax was primarily mono-
meric in unirradiated HeLa cells (n=4), a majority of Bax
(estimated at ,60% of the total by densitometry) redistributed into
high molecular weight oligomeric fractions post-irradiation (Figure
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unirradiated controls, and as previously reported [37] redistribut-
ed minimally upon irradiation (Figure S1B).
Ceramide elevation preceded Bax activation. Ceramide levels
increased up to 2.6-foldof baseline (350 pmols/10
6cells) beginning at
28 h post-20 Gy and remained elevated until at least 36 h post
irradiation (not shown; p,0.005 at all times vs. control). Whereas
sphingomyelinase activity was not elevated post-irradiation, similar to
published data [47], CS activity increased in the post-nuclear
membrane fraction (P100) at 28 h in the current studies and remained
elevated until at least 32 h [47]. Ionizing radiation increased CS
maximal reaction velocity (Vmax) of the mitochondrial-enriched
fraction specifically, as determined by Michaelis-Menten kinetics
(Figure1C),whereasERCSactivitywasnotincreased(seeFigure1E).
Consistent with this observation, the cellular ceramide increase upon
irradiation appeared confined to the mitochondrial-enriched fraction,
with no change in irradiated ER (Figure 1D).
Previous studies showed mitochondria prepared by differential
centrifugation on discontinuous sucrose gradients co-purify with
mitochondrial-associated membrane (MAM), an ER-like structure
that links to mitochondria via specific MOM contact sites and acts
as a conduit for transfer of ER and/or MAM metabolites into
mitochondria [48]. We, therefore, separated MAM from mito-
chondria to further explore the site of radiation-inducedCS activity.
Precedence exists for transfer of lipids from MAM to MOM as
phosphatidylserine (PS), synthesized exclusively in MAM via PS
synthases, is transported to MOM, then the inner mitochondrial
membrane, where it serves as the sole source of mitochondrial
phosphatidylethanolamine, via decarboxylation [49,50]. Here we
show that HeLa cell MAM, but not ER or mitochondria, is the
exclusive site of radiation-induced CS activation (Figure 1E, upper
panel) with apparent subsequent transfer of ceramide to mitochon-
dria (Figure 1E, lower panel), as 75% of the ceramide mass increase
is observed within MAM-free mitochondria. Similar transfer of
MAM ceramide to MOM was recently reported by Colombini and
co-workers [51]. In contrast, the level of total mitochondrial
phospholipid and of sphingosine-1-phosphate, a ceramide metab-
olite with second messenger function, remained unchanged (not
shown). A similar high baseline ceramide concentration and
stimulated elevation were recently detected by mass spectroscopy
in MAM-free mitochondria isolated from untreated and phorbol
ester-treated MCF-7 breast cancer cells [52].
Further evidence for preferential ceramide elevation in
mitochondria post-irradiation was derived from confocal micro-
scopic double immunostaining using anti-ceramide IgM, and anti-
COXI IgG as mitochondrial marker (Figure 1F). The anti-
ceramide antibody used is highly specific, distinguishing C16-
ceramide from C16-dihydroceramide (Figure S2), which differs
from ceramide by a double bond in the sphingoid base backbone.
While only 18.462.7% (mean6SE) of ceramide co-localized with
mitochondria (Figure 1F, upper panels, yellow merged signal) in
unirradiated cells, the level of ceramide co-localized to mitochon-
dria increased to 31.263.3% (Figure 1F, bottom panels) (p,0.001;
n=20) at 33 h post-irradiation. Similar co-localization was
displayed with Mitotracker (not shown). Alternately, no radia-
tion-induced co-localization of anti-ceramide with ER-marker
(anti-KDEL) was detected (Figure S3). Taken together, these
studies indicate that ceramide increases preferentially within HeLa
cell mitochondria during evolution of radiation-induced apoptosis.
The natural CS inhibitor, Fumonisin B1, inhibits MOMP
Fumonisin B1 (FB1) is a natural competitive CS inhibitor [53] with
an IC50 two orders of magnitude left-shifted to the Km for sphingoid
base acylation [53]. A short treatment of HeLa cells with 15 mMF B 1,
beginning 20 h post-irradiation, did not affect basal ceramide levels
but abolished radiation-induced mitochondrial ceramide elevation
(Figure 2A). FB1 also reduced Bax insertion into the MOM
(Figure 2B). In five experiments, FB1 inhibited Bax insertion by
8365% (p,0.01 vs. irradiated) and nearly completely inhibited
formation of high molecular weight Bax oligomers (Figure 2C).
Inhibition of radiation-induced Baxi n s e r t i o na n do l i g o m e r i z a t i o nb y
FB1reduced cytochromecrelease into cytosolby 72% (Figure2D, left
panel). Similar reduction was observed in bovine aortic endothelial
cells (BAEC) (Figure 2D, right panel), previously reported to undergo
radiation-induced CS activation [54]. Consequently, FB1 also
attenuated caspase 3 activation (67% at 30 mM; Figure 2E) and
inhibited apoptosis assessed by bis-benzimide staining in HeLa cells
(not shown) and BAEC [54]. Similar results were obtained using ISP-
1 (Figure 2B and not shown), an inhibitor of serine palmitoyl
transferase, the enzyme catalyzing synthesis of the sphingoid base
substrate for de novo ceramide synthesis viaCS [55].These data define
a role for ceramide generated via CS in the mitochondrial phase of
radiation-induced apoptosis in HeLa cells.
C16-ceramide activates Bax within isolated HeLa
mitochondria
To provide direct evidence that ceramide effects Bax-mediated
MOMP, isolated HeLa mitochondria were treated with natural
Figure 1. Ionizing radiation-induced ceramide elevation is confined to mitochondria. (A) Time- and dose-dependent induction of
apoptosis in response to ionizing radiation. Morphologic changes of nuclear apoptosis were detected using the DNA-specific fluorochrome bis-
benzimide. Data (mean6SEM) are collated from 3 experiments analyzing 500 cells per point. (B) Time-dependent cytochrome c (Cyt. c) release after
10 Gy. Cytosolic fractions of HeLa cells, collected at the indicated times post-irradiation were analyzed by immunoblotting using a-Cyt. c. Data are
from 1 representative of 3 studies. (C) Increased CS activity in isolated mitochondria (MT) after 20 Gy. CS activity was measured at 28 h post-
irradiation. Data are from 2 experiments. (D) Radiation increases mitochondrial ceramide content. At 33 h post-irradiation, ceramide was quantified
by the diacylglycerol kinase assay in mitochondrial-enriched and ER-enriched fractions from HeLa cells. Inset: The ER-enriched fraction was devoido f
mitochondrial contamination based on western blotting with anti-COXII (mitochondrial marker), while the mitochondrial fraction was 10.961.7%
(mean6SE) ER based on anti-Climp63 (ER marker) blotting. Data (mean6SE) are from 4 experiments performed in triplicate. *, p,0.05 vs. control. (E)
Ionizing radiation increases CS activity in MAM and ceramide levels in MAM-free mitochondria (MT). HeLa cells were harvested 33 h post-10 Gy and
organelles isolated as in Materials and Methods. ER (P100) was fractionated by differential centrifugation and mitochondria and MAM within the
heavy membrane fraction (P10) were further separated from each other by 30% Percoll gradient. Upper panel; CS activity was measured in each
fraction using sphinganine and palmitoyl-CoA as substrates as in Materials and Methods. Middle panel: purity of ER, Mitochondria and MAM fractions
was analyzed by immunoblotting with antibodies to Calnexin (ER marker) and COXII (MT marker). Based on anti-Calnexin blotting, Percoll-purified
mitochondria were 3–4% contaminated with ER. Lower panel; Ceramide levels were quantified by diacylglycerol kinase assay as in Materials and
Methods. (F) Co-localization of mitochondrial ceramide and COXI after 20 Gy. At 33 h post-irradiation, HeLa cells were stained with anti-ceramide IgM
(red) and anti-COXI IgG (green). Images were acquired with a Leica TCS AOBS SP2 confocal microscope equipped with a 6361.4NA OIL DIC D
objective combined with 46scan zoom, and co-localization (yellow) was analyzed with MetaMorph 7.5 software. Scale bar; 10 mm. Inset images
(rectangles) represent 46magnification of left upper (0 Gy) and left lower (20 Gy) regions for observation of co-localization. Data are from 1 of 5
experiments.
doi:10.1371/journal.pone.0019783.g001
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e19783Figure 2. FB1 prevents radiation-induced MOMP in HeLa cells. (A) FB1 blocks mitochondrial ceramide generation. HeLa cells were irradiated
(IR) and treated with 15 mMF B 1 20 h post-irradiation. Ceramide in isolated mitochondria was quantified by diacylglycerol kinase assay at 36 h post-
irradiation. Data (mean6SEM) are from 2 experiments performed in triplicate. *, p,0.05 vs. control; **, p,0.01 vs. irradiated. (B) FB1 prevents
radiation-induced Bax insertion into the MOM. Alkali-resistant mitochondrial fractions containing inserted Bax were isolated after 34 h from HeLa cells
irradiated with 20 Gy and treated with 25 mMF B 1 or 75 nM ISP-1 at 20 h post-irradiation. COXII was used as mitochondrial loading control. Data are
from 1 of 4 studies. (C) FB1 blocks radiation-induced Bax oligomerization. At 34 h post-irradiation, mitochondrial proteins from HeLa cells treated as in
(B) were separated by gel filtration. Data are from 2 studies. (D) FB1 attenuates radiation-induced cytochrome c release in HeLa cells and BAEC. HeLa
cells were irradiated with 10 Gy, and 15 mMF B 1 was added 20 h post-irradiation. BAEC cells were treated with 25 mMF B 1 1 h before irradiation with
5 Gy. 36 h (HeLa) and 12 h (BAEC) post-irradiation, cytosolic fractions were analyzed by immunoblotting using mouse monoclonal anti-Cyt. c and
mouse monoclonal anti-tubulin antibodies. Data are from 1 of 2 studies in HeLa and BAEC each. (E) FB1 attenuates radiation-induced caspase activity.
FB1 was added to cells 20 h after 10 Gy and caspase activity measured at 36 h post-irradiation using the fluorogenic caspase substrate Z-DEVD-AFC.
Data (mean6SEM) are from 1 of 2 investigations performed in triplicate.
doi:10.1371/journal.pone.0019783.g002
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chrome c release (Figure 3A). In contrast, treatment with anti-
apoptotic sphingosine-1-phosphate (0.05–1 mM) failed to induce
cytochrome c release under the same conditions (not shown). 1 mM
C16-ceramide also rendered the endogenous Bax known to co-
purify with HeLa mitochondria (termed attached Bax; [37,46])
resistant to alkali extraction (Figure 3B), indicating attached Bax
had inserted into the MOM. The ED50 for cytochrome c release of
approximately 0.2 mMC 16-ceramide (Figure 3A) and peak
response at 0.5 mM (Figure 3A) were right-shifted from the ED50
for Bax insertion (approximately 0.05 mMC 16-ceramide with
maximal insertion at 0.12 mM) (Figure S4).
To provide additional evidence for ceramide function in Bax
insertion, HeLa cells were pre-treated for a prolonged time (24 h)
with high FB1 doses (35–50 mM), reducing baseline mitochondrial
ceramide content from 250640 to 80640 pmols/0.05 mg mito-
chondrial protein (mean6SD) without affecting mitochondrial
cytochrome c content (Figure 3D, left panel). Sensitivity of
ceramide-depleted HeLa mitochondria towards tBid-induced cyto-
chrome c release, which depends on insertion/activation of the
endogenous Bax associated with isolated mitochondria [44], was
markedly reduced (Figure 3C). Consistent with published literature
[44], tBid-induced dose-dependent insertion of attached endogenous
Baxinto theMOM(not shown)and cytochromec release,whichwas
maximal at 2.5 ng tBid/50 mg mitochondrial protein (Figure 3C,
left). tBid-induced cytochrome c release from ceramide-depleted
mitochondria, however, was attenuated at least 5-fold (Figure 3C,
right), accompanied by inhibition of Bax insertion (not shown).
As there are two distinct events in the Bax activation process in
which lipids direct Bax insertional activation, the initial tethering
Figure 3. Effect of C16-ceramide on MOMP in isolated HeLa mitochondria. (A) Ceramide induces cytochrome c release from isolated HeLa
mitochondria. C16-ceramide (0–1 mM) was incubated with HeLa mitochondria (1 mg/ml) in MSB buffer. After 1 h at 30uC, samples were centrifuged at
14,0006g for 5 min at 4uC to separate released (supernatant) and retained (pellet) mitochondrial proteins, and analyzed for cytochrome c release by
immunoblotting using anti-Cyt.c and anti-COXII as loading control. Data are from 1 of 4 investigations. (B) Ceramide induces insertion of endogenous
Bax into HeLa mitochondrial membranes. Isolated mitochondria were incubated with 1 mMC 16-ceramide and mitochondrial pellets were collected
after incubation as in (A). Attached and inserted Bax were separated by alkali extraction of mitochondrial pellets as in Figure 2B and analyzed by
Western blot with anti-Bax and anti-COXII as loading control. Data are from 1 of 4 investigations. (C) FB1 inhibits tBid-induced cytochrome c release.
Isolated HeLa mitochondria were incubated with 0.25–12.5 ng of caspase-8 cleaved human Bid for 30 min and cytochrome c release was analyzed as
in (A). Data represent one of three similar studies. (D) FB1 inhibits BaxDC-induced cytochrome c release. HeLa mitochondria, replete (control) or
depleted of ceramide (from 35 mMF B 1-pretreated cells), were incubated with BaxDC (0–1 mM) for 30 min and cytochrome c release was analyzed as
in (A). The left panel shows the cytochrome c content of mitochondria isolated from FB1-pretreated cells was not different than that from untreated
HeLa cells. Data are from 1 of 5 investigations.
doi:10.1371/journal.pone.0019783.g003
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activation of the lipidic pore through the a5-a6 hairpin, studies
were designed to evaluate ceramide impact specifically on the
lipidic pore. For these studies we employed BaxDC, which lacks
amino acids 172–192 including the C-terminal TM domain [56].
Similar to what we observed with tBid, cytochrome c induced
release by BaxDC was reduced .1 log in ceramide-depleted
mitochondria compared to control HeLa mitochondria
(Figure 3D). Ceramide depletion also blocked Bax insertion into
the MOM of mitochondria isolated from FB1-treated BAEC (not
shown), and prevented cytochrome c release therefrom (Figure S5,
lower panel). Together these data indicate ceramide is a significant
regulator of Bax-mediated MOMP.
Ceramide induces formation of a mitochondrial
ceramide-rich macrodomain (MCRM)
The above studies are consistent with either mitochondrial
ceramide acting, like Bax, to directly release cytochrome c,o r
alternatively as a facilitator of Bax action. To resolve this issue, we
employed mouse liver mitochondrial preparations, which, in
contrast to HeLa mitochondria, are isolated without attached Bax
[46] (Figure S6). Hence, they can serve as a model to examine
autonomous ceramide action. Treatment of mouse hepatic
mitochondria with recombinant BaxDC induced concentration-
dependent cytochrome c release (Figure 4A, upper panel). As little
as 0.05 mM BaxDC was effective, and 1 mM BaxDC was maximal,
and equivalent to 150 mM CaCl2, a maximally-effective concen-
tration for permeability transition-induced release [46]. Neither
stimulus impacted the content of the MOM protein VDAC
(Figure 4A, upper panel, lower lane) or the soluble matrix protein
Hsp-60 (Figure S7), indicating specificity of the cytochrome c
release process. In contrast, C16-ceramide alone had no impact on
cytochrome c release up to 50 mM (Figure 4A, lower panel),
consistent with ceramide not functioning as a non-specific
‘‘detergent’’ effecting cytochrome c release [note ceramide is a
non-swelling amphiphile and hence by definition not a detergent
[57]]. Furthermore, when C16-ceramide was added to mouse
hepatic mitochondria prior to 0.05 mM BaxDC, a minimally-
effective dose for BaxDC alone, cytochrome c release was
dramatically enhanced. Combination of 1–5 mMC 16-ceramide
and 0.05 mM BaxDC yielded cytochrome c-releasing capacity
equivalent to 1 mM BaxDC alone, a dose-modifying factor of 20-
fold. This effect appeared specific for ceramide, as the ceramide
precursor C16-dihydroceramide was ineffective (Figure S8).
Further, the profile of proteins released from mitochondria in
response to 50 nM BaxDC plus C16-ceramide was nearly identical
to that released by 1 mM BaxDC alone measured by Coomassie
blue staining (Figure S9) and confirmed by mass spectrometry,
consistent with ceramide acting via the Bax pore. Similar results
were obtained combining C16-ceramide with full-length recombi-
nant Bax albeit with lower efficacy for cytochrome c release (not
shown), confirming published data using isolated rat liver
mitochondria [15].
Enhanced BaxDC function in the presence of 1–5 mMC 16-
ceramide, which increased mitochondrial ceramide content only
2–3 fold (Figure S8), appeared to reflect both increased Bax
insertion and effectiveness. Figure 4B shows that at 0.05 mM
BaxDC, half the mitochondrial-associated BaxDC is inserted, and
that C16-ceramide confers complete insertion, effectively doubling
the quantity of inserted BaxDC. However, as the dose-modifying
factor for cytochrome c release is 20-fold, these studies insinuate
increased apoptogenic effectiveness of inserted Bax in the presence
of ceramide. In contrast, C16-dihydroceramide did not impact
BaxDC insertion (Figure S8). Hence, ceramide is not an
autonomous apoptotic factor per se but rather serves to enhance
mitochondrial Bax insertion and function.
To ascertain whether ceramide elevation in mitochondria
results in formation of a ceramide-rich macrodomain into which
Bax inserts and oligomerizes, we employed confocal microscopy
using intact mitochondria isolated from mouse liver. Detection of
MCRMs and co-localization of ceramide with Bax were
performed using Cy3 and Cy2, probes that emit at 566 nm and
510 nm, respectively. Co-localization analysis of confocal micro-
scopic images can be affected by the resolution limit, defined by
the standard equation: 0.46lem/NA=R (lem: emission wave-
length, R: resolution, NA: numerical aperture; 1.4 in this study).
Based on this equation, the calculated resolutions for Cy3 and Cy2
are 162 nm and 146 nm, respectively, readily permitting co-
localization analysis using these probes in <1 mM-sized mito-
chondria.
After addition of C16-ceramide, and/or recombinant full-length
(FL) Bax (Figure 4C) or BaxDC (Figure 4D), mitochondria were
stained with MitoTracker (blue), and mitochondrial ceramide and
Bax were localized using anti-ceramide IgM (red) or anti-Bax IgG
(green), respectively. Control IgM and IgG did not yield detectable
signals (see Figure 5A). Consistent with the Western analysis
(Figure S6), Figures 4C and 4D show that endogenous Bax was not
immunodetected in naı ¨ve mitochondria (top lanes), while barely
detectable ceramide-containing domains were observed at low
incidence (top lanes). Very little added recombinant full length Bax
or BaxDC co-localized with these small ceramide-rich domains
(second lanes in Figures 4C and 4D, respectively). Addition of
exogenous C16-ceramide alone to naı ¨ve mitochondria resulted in
formation of large MCRMs in 65–75% of mitochondria (third
lanes and bottom lanes in Figures 4C and 4D), with recombinant
full length Bax or BaxDC co-localizing in ,70% of these newly-
formed platforms (identified as whitish-yellow merged signals in
the bottom lanes). Further, more than half of the C16-ceramide
uptake, 6065% of the total, went to manufacturing these newly-
formed MCRMs. MCRM formation was not an artifact of fixation
preceding staining as reported for the Forssman antigen on the
apical surface of MDCKII cells [58], as reversing this order did
not impact MCRM detection (Figure S10).
We next isolated these MCRMs as a detergent-resistant light
membrane fraction by continuous sucrose density flotation, a
technique commonly employed to biophysically separate GEM
platforms from bulk plasma membrane [18]. Figure 4E (middle
panel, upper lane) confirms that Bax is absent from naı ¨ve
mitochondria, and that upon incubation with BaxDC, most of
the BaxDC (71%) resolves with the high-density bulk membrane-
containing fraction (upper panel, upper lane, fractions 10–12).
This compartment contains 57% of endogenous mitochondrial
ceramide (upper panel, lower lane), and most of the MOM
proteins VDAC (56%), Bak (89%), Bcl-xL (97%), and Metaxin
(98%). Addition of 5 mMC 16-ceramide, which alone does not
effect cytochrome c release, doubled mitochondrial ceramide
content from 936 to 1812 pmol/5 mg mitochondrial protein,
largely within light sucrose density membranes (middle/lower
panels, lower lanes, fractions 1–9), consistent with the confocal
data showing that the majority of ceramide added goes to
formation of MCRMs. In contrast to studies using BaxDC alone,
upon co-addition of BaxDC and ceramide, a combination that
releases most mitochondrial cytochrome c (see Figure 4A), 68% of
BaxDC resolves with the MCRMs (lower panel, upper lane,
fractions 1–9). C16-dihydroceramide did not induce BaxDC
translocation into the light membrane fraction (Figure S10). A
substantial portion of VDAC and a modest amount of Bak (lower
panel, middle lanes), cholesterol (Figure S11) and various
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PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e19783Figure 4. Ceramide is non-apoptogenic by itself and facilitates Bax-induced MOMP. (A) Ceramide facilitates Bax-induced cytochrome c
release from isolated mouse liver mitochondria ex vivo. Recombinant BaxDC (0–1 mM, upper panel), or C16-ceramide (0–50 mM) plus 0.05 mM BaxDC
(lower panel) were incubated with isolated mouse liver mitochondria (1 mg/ml) in KCl buffer for 5 min at 37uC, supernatants and pellets were
separated by centrifugation at 14,0006g for 5 min at 4uC, and cytochrome c release was measured as in Figure 3A. The outer mitochondrial
membrane protein VDAC was used as loading control. Data are from 3 studies. (B) Ceramide induces insertion of recombinant BaxDC into isolated
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compartment upon C16-ceramide treatment, while Bcl-xL and
several other membrane proteins remained within the high-density
fraction (Figure 4E and Figure S11). Taken together, these data
indicate that two distinct approaches, biophysical isolation and
confocal microscopy, identify a ceramide-rich macrodomain
where Bax and other MOMP-inducing proteins associate. How
MCRMs bestow Bax pore-forming capability is not addressed in
this study, although the data are consistent with MCRMs
constituting an essential element of the proteolipid Bax pore that
appears to regulate MOMP [7,9].
Ionizing radiation generates an endogenous MCRM in
HeLa mitochondrial membranes
A similar approach was used to demonstrate MCRMs in
irradiated HeLa mitochondria, which engage endogenous full-
length Bax to mediate MOMP. While mitochondria isolated from
unirradiated HeLa cells are decorated with attached but
uninserted endogenous Bax (see Figure 3B, Figure S4), only
1764% of these mitochondria manifest ceramide-rich domains,
which tend to be small and contain minimal Bax by confocal
microscopy (Figure 5A, upper lanes, n=4). However, at 33 h post-
10 Gy, MCRMs were detected in 4164% of the total mitochon-
drial population (p,0.001). Up to 80% of the ceramide
synthesized de novo (in 5 experiments 66613% mean6SD) upon
irradiation was utilized to construct these MCRMs. Hence
MCRM ceramide rather than free ceramide would appear to be
responsible for functionalizing Bax. Furthermore, the localization
of Bax in MCRMs increased 14-fold after irradiation compared to
that in the small ceramide-containing domains of control
mitochondria (p,0.001), with 50% of the MCRMs displaying a
Bax co-signal. Addition of 1 mMC 16-ceramide to generate
MCRMs in mitochondria isolated from control unirradiated
HeLa cells, which maximally releases cytochrome c (see Figure 3A),
mimicked ionizing radiation conferring Bax co-localization (typical
image depicted in Figure 5B) in 56% of HeLa MCRMs (p,0.001
vs. control 0 mM ceramide).
Consistent with these confocal observations, biophysical isola-
tion of ceramide-rich domains by either discontinuous (identified
as the 5% sucrose light membrane fraction; Figure 5C) or
continuous (Figure S12) sucrose density flotation 34 h post-10 Gy
revealed that 80.4612.0% of the radiation-induced mitochondrial
ceramide elevation reported in Figure 1E was confined to the
HeLa light membrane fraction post-radiation (not shown). These
data are consistent with results where exogenous C16-ceramide
added to isolated mouse liver mitochondria largely localized to this
fraction (Figure 4E). Cholesterol was similarly concentrated in
ceramide-rich light membranes post-radiation (Figure 5C). While
a portion of Bak (20.261.1%) and VDAC (16.761.6%)
constitutively associated with HeLa ceramide-rich light mem-
branes, all other mitochondrial proteins tested, including Bcl-xL,
were largely absent (Figure 5C and Figure S12). Little of the Bax
(,5–6%) associated with mitochondria in unirradiated HeLa cells
resolved with ceramide-poor light membranes. However, after
irradiation a substantial portion of the Bax pool (46%) localized to
ceramide-rich light membranes. In eight experiments, we observed
a 6.760.5 fold increase in light membrane-associated Bax
(Figure 5C, lower panel; p,0.001). Thus two separate but
complementary approaches, sucrose density floatation and
confocal microscopy, confirm radiation-induced generation of
mitochondrial MCRMs that coordinates Bax insertion/oligomer-
ization required for MOMP.
HeLa cell MCRMs contain high molecular weight
oligomerized endogenous Bax
Because Bax oligomerization is an essential element of MOMP
induction, the multimerization status of endogenous Bax within
MCRMs was assessed post-irradiation. To assure that Bax
multimerization within MCRMs was not an artifact of membrane
lipid isolation, MCRMs were initially isolated either using 1–2%
CHAPS, which does not impact low molecular weight homo-
dimerization [37,59], or 0.15% Triton X-100, known to induce
low molecular weight homodimerization [37,59]. After MCRMs
were isolated, the molecular weight profile of associated Bax was
defined by size exclusion chromatography. Isolation in CHAPS
(Figure 5D, upper panels) revealed that MCRMs contained high
molecular weight Bax oligomers exclusively, while the heavy
fraction contained Bax monomers. A similar profile was identified
using 0.15% Triton X-100 (Figure 5D, lower panels), except the
molecular weight of Bax was slightly higher in these heavy
fractions consistent with Bax-Bax homotypic interaction, as
reported when using Triton X-100 [37]. VDAC and Bak were
also found in MCRM high molecular weight oligomers, and in
both high and low molecular weight fractions of heavy
membranes. These studies define the MCRM as a site of
preferential Bax oligomerization.
Discussion
The present studies show that ceramide, formed upon ionizing
radiation exposure, regulates Bax insertion, oligomerization and
MOMP. As up to 80% of the radiation-generated ceramide in
HeLa mitochondria resides in newly-formed MCRMs, and as a
burgeoning literature defines plasma membrane CRMs as sites of
protein sorting and oligomerization for transmembrane signaling
(for review see [27]), the most parsimonious explanation for the
mouse liver mitochondria. Mitochondria were treated as in (A) and attached and inserted BaxDC analyzed as in Figure 3B. Data are from 2
independent studies. (C) Full-length (FL) Bax co-localizes with MCRMs induced by exogenous C16-ceramide. Mouse liver mitochondria were incubated
in MSB-based medium in the presence or absence of 50 nM full-length Bax for 5 min at 30uC. Thereafter, 0 or 1 mM C16-ceramide [1% final solvent
concentration (ethanol:dodecane, 98:2 v/v)] was added to the mixture for an additional 10 min. Mitochondria were fixed and stained with
MitoTracker (blue), and ceramide and Bax were localized using anti-ceramide IgM (red) or anti-Bax IgG (green), respectively. Images, acquired with a
Leica TCS AOBS SP2 confocal microscope equipped with a 10061.4NA OIL DIC D objective combined with 26 scan zoom, were analyzed with
MetaMorph 7.5 software. Control IgM and IgG did not yield detectable signals (not shown). Scale bar; 1 mm. Data represent 1 of 3 similar studies. (D)
BaxDC co-localizes with MCRMs induced by exogenous C16-ceramide. Experiments were performed as in (C) using 5 mM C16-ceramide [1% final
solvent concentration (ethanol:dodecane, 98:2 v/v)] in the presence or absence of 50 nM recombinant BaxDC. Scale bar; 1 mm. Data represent 1 of 4
similar studies. (E) Biophysical isolation of mouse liver MCRMs. After incubation with 50 nM BaxDC and 5 mMC 16-ceramide, mitochondria (3.3 mg/ml),
pelleted as in Figure 4A were resuspended in cold MBS buffer containing 0.05% Triton X-100. After 30 min on ice, mitochondria were homogenized
with 20 strokes of a loose-fitting dounce homogenizer. The mitochondrial homogenate was adjusted to 40% final sucrose concentration and
subjected to 5–30% continuous sucrose density gradient as in Materials and Methods. 400 ml of each 1 ml fraction were concentrated by 20% TCA
precipitation, and proteins were resolved on a 15% SDS-PAGE gel and identified by immunoblot analysis using antibodies to the indicated proteins.
Ceramide was measured using 400 ml aliquots by diacylglycerol kinase assay. Data are from 3 independent studies.
doi:10.1371/journal.pone.0019783.g004
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PLoS ONE | www.plosone.org 13 June 2011 | Volume 6 | Issue 6 | e19783current data set is that MCRMs, and not the small amount of free
ceramide, represent the structure that functionalizes Bax.
Consistent with this concept, all of the radiation-generated
ceramide is found in a different physical state than the ceramide
in resting HeLa cells. Whereas ceramide in resting cells is not
found in macrodomains by confocal microscopy and associates
with the heavy fraction by sucrose density flotation, the ceramide
in irradiated cells is detected by confocal microscopy as MCRMs
and by biophysical isolation in light membranes. This is identical
to the pattern of resolution of plasma membrane CRMs by these
same technologies.
An extensive literature exists regarding the capacity of ceramide
to spontaneously form macrodomains in model membrane systems
[57]. This is a rare property of lipids, resulting primarily from the
capacity of the sphingoid base backbone of ceramide to network
hydrogen bonds, and also via Van der Waal and hydrophobic
forces [60]. Similar properties are detected upon addition of long
chain ceramide to the exoplasmic surface of most mammalian cells
or upon treatment of these cells with exogenous sphingomyelinase
[61]. The current hypothesis in this field is that each membrane
has a threshold level of ceramide that will yield a platform once
achieved. Published experimental data support this suggestion
[62]. Additionally, at least in model membranes, platform
formation in an intrinsic property of ceramide, not requiring
protein [57]. Our previous studies on plasma membrane responses
during UV and Fas stress are consistent with the notion that
ceramide primarily functions as membrane structure re-organizer.
Those experiments showed that while ceramide elevation
conferred plasma membrane platform formation, this event alone
did not mimic stress signaling, as protein insertion and
oligomerization were required for transmembrane signaling [29].
Here we extend these concepts to the MOM, showing that
ceramide addition to mouse liver mitochondria confers an MCRM
but not cytochrome c release (Figure 4), which additionally
requires Bax function. These data differ from those of Colombini
and co-workers, who provided evidence that ceramide alone at
physiologic concentrations was capable of inducing MOMP
[15,63]. While we do not have an explanation for the difference
between the current study and those of Colombini and co-workers,
like ourselves, Kronke and co-workers [17] and Farber and co-
workers [16] observed that ceramide synergized with Bax to
induce MOMP, but did not act alone. Perhaps the use of different
methods of delivery could be the source of the observed differences
in the results.
The current studies provide a structural explanation for an
emerging database on the role of ceramide in MOMP. Prior
studies suggested that C16-ceramide, generated in the mitochon-
drial associated membrane [51] via Cers 5 and Cers 6 [47], traffics
to the MOM where it synergizes with Bax in regulating
cytochrome c release ([15] and current study). This is conceptually
similar to the role of de novo synthesized ceramide at the outer
mitochondrial membrane in radiation-induced apoptosis in the C.
elegans germline [1], consistent with an evolutionary conservation
of function. The advance of the current study is that a
mitochondrial compartment that forms upon stress can be
visualized and isolated (see similar data in [64]), and is
pharmacologically-tractable, providing new opportunities for
therapeutic manipulation of the death program.
Comparison of the ED50 for ceramide-mediated Bax insertion
and for cytochrome c release indicates MCRMs improve Bax
function as transducer of MOMP beyond enhancing Bax
insertion. Whether this results from preferential Bax oligomeriza-
tion within this specialized compartment, or whether MCRMs
additionally facilitate Bax conformation as a ‘‘pore’’, is currently
unknown. Although the present studies do not attempt to
distinguish the relative contribution of MCRM-mediated Bax
insertion versus oligomerization in MOMP induction, it should
nonetheless be emphasized that Bax oligomerization is fundamen-
tal to the process. Furthermore, although the constituents of a
functional MCRM capable of yielding an active Bax pore remain
largely unknown, we suggest that there is a core set of lipids and
proteins that form the basic MCRM structure, which may be
modified in a cell type and stress type manner. Thus it is
anticipated that different stresses that utilize different pro-
apoptotic Bcl-2 family members to initiate MOMP will accord-
ingly generate MCRMs with distinct profiles.
It is also possible that inserted Bax may contribute to further
MCRM organization, enabling recruitment or modification of
specific proteins or lipids to form the active pore. This possibility is
supported by observations made on pore-forming colicins. The
inserted anti-parallel hairpin of colicins, like that of Bax [5],
appears too short to span the membrane bilayer requiring
membrane alterations upon hairpin insertion to enable pore
function [9]. These studies demonstrated a toroidal structure
forms within the bilayer upon hairpin insertion [9,65], where pore
walls interact directly with specific membrane lipids, such as
cardiolipin, to generate a non-bilayer inverted micellar-like
structure, conferred by hexagonal phase transition. This mem-
brane conversion purportedly allows bilayer ‘‘thinning’’ permitting
shorter peptides to extend through the bilayer. Relevant to this
notion, long-chain ceramide represents one of only few lipids that
have the propensity to spontaneously ‘‘destabilize’’ membranes by
Figure 5. Ceramide induces formation of a mitochondrial ceramide-rich macrodomain (MCRM). (A) Ionizing radiation (10 Gy) induces co-
localization of endogenous Bax with MCRMs in HeLa cells. Mitochondria were isolated from HeLa cells 34 h after irradiation and immunostained as
described in Supporting Information Text S1. Data represent typical stainings from 1 of 4 similar studies in which 2000 mitochondria were analyzed
each. (B) Addition of exogenous C16-ceramide induces co-localization of endogenous full-length Bax with MCRMs in HeLa cells. Mitochondria were
isolated from HeLa cells using percoll gradient and treated with ceramide as Figure 3A. After 30 min incubation, mitochondria were fixed and stained
with MitoTracker (blue), while ceramide and Bax were localized using anti-ceramide IgM (red) or anti-Bax IgG (green), respectively. Control IgM and
IgG did not yield detectable signals (not shown). These data represent 1 of 3 similar studies. (C) Bax translocates into a radiation-generated HeLa
MCRM. Upper panel: 34 h post-irradiation, HeLa mitochondria were isolated as in Materials and Methods and incubated with 0.15% Triton X-100 in
MBS buffer for 30 min on ice. 40 ml mitochondrial homogenate (3.3 mg/ml) were subjected to 5–30% mini-discontinuous sucrose density gradient
centrifugation as described in Materials and Methods. 20 ml aliquots of 80 ml fractions were analyzed by immunoblotting using the indicated
antibodies. The protein level of each fraction was assessed using the Bio-Rad Dc protein assay kit (PE, Pellet). Data are from 1 of 4 studies, consisting
of 2 independent gradients per study. The gradient shown displays our clearest example of Bax translocation into light membranes. Lower panel: Bax
in each fraction, revealed by immunoblotting and quantified using NIH Image software, was normalized to protein content for all 8 gradients. (D)
MCRM Bax exists as high molecular weight oligomers. Mitochondria from 10 Gy-irradiated HeLa cells, disrupted by either (a) 1% CHAPS and
sonication or (b) dounce homogenization in 0.15% Triton X-100, were subjected to 5–30% discontinuous sucrose gradient for MCRM isolation as in
Experimental Procedures. Light (MCRM; fractions 6,7) and heavy fractions (solubilized proteins; fractions 11,12) were analyzed by gel filtration on
Sephacryl S-200 column as in Figure 2C. 500 ml of each eluted fraction were concentrated by 20% TCA precipitation for immunoblotting. Data are
from 3 independent studies.
doi:10.1371/journal.pone.0019783.g005
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present data do not address the question whether ceramide
directly participates in Bax pore structure, we posit that the
biophysical property of ceramide to ‘‘destabilize’’ membranes may
be crucial for conversion of inserted Bax into an open pore,
regulating MOMP. This hypothesis, and whether the toroidal
structure confers oligomerization or vice versa, requires further
study.
The present studies also indicate that in the HeLa cell system,
radiation activates CS within MAM, with apparent transfer of
synthesized ceramide to MOM, as CS elevation is found only in
MAM whereas the mass of ceramide increase is in the contiguous
MOM. Understanding these events mechanistically is beyond the
scope of the present studies, although the present studies do add to
a growing literature indicating a role for ceramide in mitochon-
drial membranes in some forms of apoptosis [11,15,16,47,64].
Further, while our data indicate ceramide engagement in
organizing MCRMs, the data do not preclude ceramide also
acting at an earlier ‘‘pre-pore’’ stage of Bax activation. Recent
studies reported C2-ceramide stimulates Bax conformational
changes via PP2A-mediated Ser184 dephosphorylation [69].
However, our use of BaxDC in the MCRM deconstruction
studies, which lacks Ser184, restricts our observations to
confirming a direct effect of ceramide on MOM reorganization
to facilitate Bax insertion and oligomerization. Profiling for known
pro-apoptotic (Bax, Bak, Bim, Bid, PUMA, VDAC), anti-
apoptotic (Bcl-xL, Hsp60), and non-apoptotic (COXII, Metaxin,
PDH E1a) proteins, which exist in distinct mitochondrial
compartments, revealed assembly of Bax, Bak, and VDAC in
ceramide-activated HeLa and mouse liver mitochondria MCRMs
is selective, as all other proteins tested were confined to heavy
membranes. It should be noted that mouse liver mitochondria,
which are isolated without attached Bax, display no VDAC or Bak
in the light membrane fraction prior to ceramide addition. In
contrast, HeLa cell mitochondria, which purify with Bax attached
and a minor portion inserted into the MCRM, display VDAC and
Bak constitutively within their light membranes pre-radiation.
Differences in the pattern of cholesterol concentration within liver
and HeLa cell MCRMs were also noted (compare Figure S11 to
Figure 5C). While reasons for these differences are currently
unknown, ultimately Bax, Bak and VDAC concentrate specifically
within MCRMs, segregated from Bcl-xL in both systems.
Although the present data does not address the functional
implications of MCRM separation of Bax and Bak from Bcl-xL,
nonetheless this finding may be of potential significance. Future
studies are required to further profile proteins within the MCRM
and how they are selected, and to determine how ceramide
induces preferential concentration of cholesterol and select
glycosphingolipids within this compartment.
Coupling of CS, Bax insertion/oligomerization and MOMP in the
pathogenesis of mitochondrial apoptosis sheds new light on CS in
cellular and tissue responses to stress. CS has recently emerged as a
cell-type specific mediator of apoptosis for diverse stresses in vitro
[32,54,70,71,72], and as transactivator of disease pathogenesis in
experimental models of human disease, including gastric ulcer in rats
[73], radiation-mucositis in hamsters [74], VEGF receptor inhibitor
(SU5416)-induced emphysema in rodents [75], and the radiation-
induced GI syndrome in atm
2/2 mice [76]. In these disease models,
CS-mediated tissue damage was significantly attenuated by FB1,
leading to prevention or recovery from the stress-induced experi-
mental syndrome. The present demonstration of the CS/Bax/
MOMP linkage may have substantive implications for understanding
normal tissue physiology and disease pathogenesis, potentially
providing unique opportunities for targeted therapies.
Supporting Information
Figure S1 Ionizing radiation induces Bax insertion and
oligomerization. (A) Time-dependent Bax insertion after
10 Gy. Mitochondria isolated from HeLa cells at the indicated
times post-irradiation were resuspended in 0.1 M Na2CO3,
pH 11.5 (1 mg/ml) and incubated on ice for 1 h. 20 ml aliquots
were analyzed for total Bax (upper panel, bottom lane). The
remaining 80 ml were centrifuged at 100,0006g at 4uC for 30 min
to separate alkali-sensitive (supernatant) and alkali-resistant (pellet)
mitochondrial proteins. The pellet, containing Bax inserted into
the MOM, was resuspended in 80 ml SHE buffer with 2% CHAPS
and 20 ml aliquots of each fraction were immunoblotted using
anti-Bax (N-20) and anti-COXII antibodies (upper panels), and
quantified using NIH Image software (lower panel). The Bax/
COXII ratio in unirradiated control (Co) at 36 h was arbitrarily
valued of 1.0. Data represent 6 independent studies. (B) Bax
oligomerization induced by irradiation. 34 h post-10 Gy, mito-
chondrial proteins extracted with 2% CHAPS buffer were
separated by size on a Sephacryl S-200 gel filtration column
equilibrated with 1% CHAPS buffer at a flow rate of 0.5 ml/min.
400 ml aliquots of each 1 ml collected fraction were concentrated
by 20% TCA precipitation, and immunoblotted using anti-Bax,
anti-Bak and anti-VDAC antibodies. Data are from 1 of 4
independent studies.
(TIF)
Figure S2 Validation of the specificity and sensitivity of
the ceramide antibody MID 15B4 by immune TLC.
1 mmol of C16-ceramide, C16-dihydroceramide, and sphingomy-
elin were separated on a silica gel 60 A ˚ TLC plates using
chloroform: acetone: methanol: acetic acid: water (10:4:3:2:1, v/v)
as solvent. Plates were blocked overnight with 4% BSA at 4uC.
After washing, plates were incubated with the anti-ceramide
antibodies MID 15B4 (final concentration 6 mg/ml) at 4uC for 2 h
followed by alkaline phosphatase-coupled anti-mouse IgM anti-
body for 2 h at room temperature. Plates were washed and lipids
visualized with Tropix chemiluminescence kit. This figure is
representative of 3 similar studies.
(TIF)
Figure S3 Co-localization of anti-ceramide with anti-
KDEL before and after 10 Gy in HeLa cells. At 36 h post-
irradiation, HeLa cells were stained with anti-ceramide IgM
(green) and anti-KDEL (red). Images were obtained using a Zeiss
LSM 510 confocal microscope fitted with a663 objective and co-
localization analysis was performed with LSM 510 v.2.8 software.
Pixel overlap between two scans (i.e., Texas-Red and Cy2) of the
same specimen is presented as a scatter diagram. Two pixels (P1, a
pixel from the scan of the red channel and P2, a pixel from the
scan of the green channel) with the exact same position in both
scans are considered a pair (P1, P2). In the scatter diagram, the
brightness level of P1 is plotted on the X coordinate and that of P2
on the Y coordinate. Each dot on the scatter diagram represents
the pixel pair. Relative frequency of occurrence of a particular pair
of pixels is expressed with different colors (red.orange.yellow.-
green.blue.black) representing highest to lowest frequency.
Thus, two completely identical scans would result in a straight
diagonal line from bottom left to top right on the diagram, while
the diagram will show scattered dots in case of insignificant co-
localization. The specific level of co-localization was quantified
after threshold intensities of the two fluorophores were adjusted by
subtracting non cell-associated background pixels from the scatter
diagram. In control cells (0 Gy) the scatter diagram of ceramide
and KDEL staining was detected in the 45 degrees axial position,
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irradiated sample the scatter diagram is closer to horizontal plane,
indicating reduced co-localization of ceramide and KDEL after
irradiation. Data are from 1 of 4 experiments.
(TIF)
Figure S4 Ceramide induces insertion of endogenous
Bax into HeLa mitochondrial membranes. Isolated mito-
chondria were incubated with 0–1 mMC 16-ceramide and
mitochondrial pellets were collected after incubation as in
Figure 3A. Attached and inserted Bax were separated by alkali
extraction of mitochondrial pellet as in Figure 2B and analyzed by
Western blot with anti-Bax and anti-COXII as loading control.
(TIF)
Figure S5 Inhibition of GST-BaxDC induced cytochrome
c release from mitochondria isolated from FB1-treated
HeLa cells or BAEC. Upper panel: Mitochondria were isolated
from 50 mMF B 1-pretreated or untreated HeLa cells and
incubated in MSB buffer (1 mg mitochondrial protein/ml) with
4 mM GST-BaxDC for 1 h at 30uC. After incubation, mitochon-
dria were pelleted by centrifugation at 14,0006g for 5 min at 4uC,
and supernatants analyzed for cytochrome c release by Western
blotting. Lower panel: Mitochondria were isolated from 50 mM
FB1-pretreated or untreated BAEC. After incubation with GST-
BaxDC (0–3 mM) in MSB buffer (1 mg mitochondrial protein/ml),
mitochondria were pelleted, and the resulting supernatants
analyzed for cytochrome c release. These data are from 1
representative of 3 independent investigations each.
(TIF)
Figure S6 Purity of isolated mouse liver mitochondria.
Organelles were isolated from 8-week-old C57BL/6 mouse liver
by sequential gravity centrifugation as described in Materials and
Methods. All steps were performed at 4uC. Briefly, mouse liver
homogenate in Buffer A (0.25 M sucrose, 10 mM HEPES pH 7.4,
0.5 mM EGTA) was centrifuged at 6006g for 15 min to remove
nuclei, cell debris and unbroken cells. The post-nuclear supernate
was then centrifuged at 10,0006g for 15 min to separate heavy
membranes (P10) from the cytosol and light membrane fraction
(S10). This supernatant was further centrifuged at 100,0006g for
1 h to separate cytosol (S100) from microsomes (P100). The heavy
membrane fraction (P10) was washed 4 more times by centrifu-
gation at 10,0006g for 15 min to remove microsomal contami-
nation. 15 mg of each fraction were analyzed by Western blot
using specific organelle markers; Na
+/K
+-ATPase (plasma mem-
brane), Sec61 (ER), Flotillin-1 (plasma membrane), COX IV
(mitochondria). Western blot with anti-Bax (N20) shows that
isolated mouse liver mitochondria are free of Bax as reported
previously [46].
(TIF)
Figure S7 C16-ceramide enhances Bax-induced cyto-
chrome c release without disrupting the inner mito-
chondrial membrane of isolated mouse liver mitochon-
dria. Mitochondria were isolated from mouse liver by differential
centrifugation and treated with C16-ceramide and 50 nM BaxDC
as described in Materials and Methods. While cytochrome c was
released by addition of C16-ceramide and 50 nM BaxDC, the
soluble mitochondrial matrix protein Hsp60 was retained in
mitochondria.
(TIF)
Figure S8 C16-ceramide and C16-dihydroceramide up-
take by isolated mouse liver mitochondria and their
effect on BaxDC insertion and cytochrome c release.
Upper panel: C16-ceramide or C16-dihydroceramide was added to
5 mg mitochondria in 16KCl buffer (1 mg mitochondrial prot./
ml) and incubated for 5 min at 37uC. Mitochondrial pellets were
collected by centrifugation for 10 min at 10,0006g at 4uC, and
lipids were extracted and ceramide and dihydroceramide were
measured using the diacylglycerol kinase assay as in Materials and
Methods. Lower panel: 1 mMC 16-ceramide or C16-dihydrocer-
amide was incubated with or without 50 nM BaxDC with
mitochondria and BaxDC insertion (left) and cytochrome c release
(right) were analyzed as in Figure 4A and B.
(TIF)
Figure S9 Profile of the proteins released from isolated
mouse liver mitochondria by exogenous C16-ceramide
and recombinant BaxDC. Mitochondria isolated from mouse
liver were incubated with KCl buffer (1 mg mitochondrial
protein/ml) without BSA for 5 min at 37uC with C16-ceramide
and BaxDC as indicated. After incubation, reaction samples were
centrifuged at 14,0006g for 5 min at 4uC and the supernatants
containing proteins released from mitochondria were collected
and analyzed by Coomassie blue staining (15 mg/lane; upper
panel) or by immunoblotting (15 mg/lane) with anti-cytochrome c
(lower panel). The control (CO) profile in the absence of either
BaxDC or ceramide is very similar to that observed in isolated rat
liver mitochondria [77]. 50 nM BaxDC plus 5 mMC 16-ceramide
and 1 mM BaxDC display a nearly-identical set of additionally
released proteins, marked by asterisks (*), indicative of the same
release mechanism. Further, no inner mitochondrial space
proteins over 116 kD in size were released by 50 nM BaxDC
plus 5 mMC 16-ceramide or 1 mM BaxDC, as confirmed by mass
spectrometry, consistent with published literature that defines the
maximal size of proteins released through the Bax pore as 123 kD
[78].
(TIF)
Figure S10 The effect of fixation on the staining of
MCRM using anti-ceramide IgM. It has been reported by
Butor et al. [58] that in some instances secondary antibodies
induce clustering of lipids on cell surfaces, rectified if the fixation
step is carried out after the first antibody-labeling step. To exclude
this possibility, we compared the staining profile of MCRMs using
anti-ceramide IgM with or without fixation using 2% formalde-
hyde. Mouse hepatic mitochondria were isolated and treated with
0 mM or 5 mM ceramide for 5 min at 37uC to induce MCRM
formation as described in Materials and Methods. After incubation
with blocking solution (3% FBS/3% goat serum) containing
200 nM Mitotracker for 60 min on ice, one set of samples was
stained directly with anti-ceramide IgM, followed by fixation with
2% formaldehyde and the other was fixed with 2% formaldehyde,
then stained with anti-ceramide. Mitochondria were subsequently
incubated with secondary anti-IgM antibody and mounted on
slides. Images, acquired with a Leica TCS AOBS SP2 confocal
microscope equipped with a 10061.4NA OIL DIC D objective
combined with 26 scan zoom, were analyzed with MetaMorph
7.5 software.
(TIF)
Figure S11 Distribution of mouse liver mitochondrial
proteins in 5–30% continuous sucrose density gradient.
After incubation for 5 min at 37uC with 50 nM BaxDC with or
without 5 mMC 16-ceramide, mitochondria were pelleted by
centrifugation at 10,0006g for 10 min at 4uC and resuspended
in cold MBS buffer containing 0.05% Triton X-100. After 30 min
incubation on ice, mitochondria were homogenized with 20
strokes of a loose-fitting dounce homogenizer. The mitochondrial
homogenate was adjusted to 40% final sucrose concentration and
subjected to 5–30% continuous sucrose density gradient centrifu-
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fraction was used for immunoblot analysis using the indicated
antibodies as in Figure 4E. A set of pro-apoptotic proteins
including (Bax, Bak, Bim, Bid, PUMA, VDAC), anti-apoptotic
proteins (Bcl-xL, Hsp60), and non-apoptotic proteins (COXII,
Metaxin, PDH E1a) that exist in distinct compartments were
examined. While Bax, Bak, Bim, Bid, PUMA, VDAC, Metaxin
and Bcl-xL are outer membrane proteins, COXII is an inner
membrane protein and Hsp60 and PDH E1a are matrix proteins.
(TIF)
Figure S12 Ionizing radiation (10 Gy) induces specific
translocation of Bax into HeLa cell MCRMs. Mitochondria
were isolated from HeLa cells 34 h after irradiation and incubated
with 0.15% Triton X-100 in MBS buffer for 30 min on ice. The
mitochondrial suspension was homogenized with 20 strokes of a
loose-fitting dounce homogenizer, adjusted to 40% final sucrose
concentration and subjected to 5–30% continuous sucrose density
gradient centrifugation as described in Experimental Procedures.
400 ml aliquots from each fraction were analyzed by Western
blotting using the indicated antibodies after 20% TCA precipita-
tion.
(TIF)
Text S1
(DOC)
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